29 September 2016 in Journal of the American Geriatrics Society
2 August 2016 in Neurocase
Apathy is a common neurobehavioral sign in cases of behavioral variant frontotemporal dementia. However, there is still no established sustained effective treatment. We present the case of a 65-year-old man with behavioral variant frontotemporal dementia who suffered from severe apathy, but his apathy improved after a 10-month period of bupropion treatment. His single photon emission computed tomography report also showed slight improvement. To the best of our knowledge, such a case with imaging evidence has never been reported. Further studies to correlate the effects of bupropion on apathy in behavioral variant frontotemporal dementia patients are clearly needed.
1 October 2017 in Schizophrenia Research
30 May 2023 in Clinical Psychopharmacology and Neuroscience
Pao-Huan Chen, Chun-Ming Shih, Chi-Kang Chang, Chia-Pei Lin, Yung-Han Chang, Hsin-Chien Lee, El-Wui Loh. Clin Psychopharmacol Neurosci 2023;21:262-70. https://doi.org/10.9758/cpn.2023.21.2.262
1 January 2020 in Medicine
Inappropriate care for patients with cognitive dysfunction in the hospital could worsen quality of care and medical service satisfaction. All elderly participants were recruited from acute wards of 5 departments in an university hospital. They were administered the Chinese version of Ascertain Dementia 8 (AD8) at admission and the Nursing Service Satisfaction Questionnaire before discharge. A total of 345 participants completed the study. There were 91 (26.4%) participants with AD8 ≥ 2, the cut-off value of high risk of dementia. The prevalence was much higher than prior community-based reports. The Nursing Service Satisfaction Score was significantly lower in AD8 ≥ 2 than in AD8 < 2 (56.99 ± 0.94 vs 60.55 ± 0.48, P < .01). Using AD8 in hospital-based screening might be more efficient than in the community in terms of cost-effectiveness due to higher positive rate and easier approach to diagnostic facilities. AD8 ≥ 2 is also an indicator to identify care dissatisfaction among inpatients. By identifying patients with cognitive dysfunction, such as its related communication barriers, care systems could be tailored for more friendly services.
3 September 2026 in Clinical Psychopharmacology and Neuroscience
Pao-Huan Chen, Shuo-Ju Chiang, Chi-Kang Chang, Chia-Pei Lin, Shang-Ying Tsai. Clin Psychopharmacol Neurosci -0001;0:. https://doi.org/10.9758/cpn.26.1460